arrow
T

Tamara Castillo-Triviño

hospital universitario donostia
H指数:24
被引数:2,252

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis

在复发缓解型多发性硬化中,针对临床静息期MRI病灶的治疗升级

Brain
IF11.7
2026-07-240
OAAI
Causal effects of multiple sclerosis therapies in left-truncated registry data

多发性硬化疗法在左截断登记数据中的因果效应

2026-07-210
PRE
Relevance of serum neurofilament light chain determination as a biomarker in multiple sclerosis. Consensus of the Spanish Society of Neurology's Study Group on Multiple Sclerosis and Related Neuroimmune Diseases

血清神经丝轻链检测作为多发性硬化生物标志物的相关性。西班牙神经病学学会多发性硬化及相关神经免疫疾病研究小组的共识

2025-10-100
OAAI
Targeted plasma proteomics uncover proteins associated with KIF5A-linked SPG10 and ALS spectrum disorders

靶向血浆蛋白质组学揭示了与KIF5A相关的SPG10和ALS谱系障碍相关的蛋白质

2025-08-270
OAAI
Persistent progression independent of relapse activity in multiple sclerosis

多发性硬化中与复发活动无关的持续性进展

2025-08-210
OAAI
Personalized federated learning for predicting disability progression in multiple sclerosis using real-world routine clinical data

基于真实世界常规临床数据的个性化联邦学习在预测多发性硬化致残进展中的应用

2025-07-240
OAAI
Four years on: Pregnancy and birth outcomes reported in the MSBase pregnancy, neonatal outcomes, and Women’s Health Registry (2020–2024)

四年之后:MSBase妊娠、新生儿结局及女性健康登记册(2020–2024)中报告的妊娠与分娩结局

2025-07-070
PRE
Economic burden of secondary progressive multiple sclerosis: DISCOVER study

继发性进展型多发性硬化症的经济负担:DISCOVER研究

2025-04-100
OA
Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis
2024-07-011
OAAI
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis

血清生物标志物水平预测原发性进行性多发性硬化患者的残疾进展

2023-11-086
PRE
Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
2023-10-200
OAAI
Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial

多种疾病改善疗法在复发缓解型多发性硬化症中的有效性: 模拟多臂随机试验的因果推断

2023-07-062
PRE
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

继发性进行性多发性硬化症的风险由地理位置决定,但可以改变

BRAIN
IF11.7
2023-06-275
OAAI
Hopelessness in Patients with Early-Stage Sclerosis
2023-06-013
OAAI